DPB-18660-70669
2 vaccinations
1 coded response
20 check-ins
1 free-text entry
0 call cases
- Sex
- Male
- Age at first dose
- 05-11
- ZIP prefix
- 605 / IL
- Registered
- 2022-04-30
- Relationship
- Child or adolescent in my care
- Guardian
- ZFN-32949-24119
- Race
- White
- Ethnicity
- Hispanic or Latino
Timeline
-
2022-04-30
Registered in v-safe
-
2022-04-30
Dose 1 — Pfizer-BioNTech
- 2022-05-01
- 2022-05-02
- 2022-05-04
- 2022-05-05
- 2022-05-06
- 2022-05-08
- 2022-05-14
-
2022-05-21
Dose 2 — Pfizer-BioNTech
-
2022-05-23
Health check-in — days 1–6 daily, dose 2, dependentFeeling: Good · Site: Pain · Headache, Fatigue or tirednessAdult check-in
- 2022-05-24
- 2022-05-25
- 2022-05-26
-
2022-05-27
Survey response — days 1–6 daily, dose 2, dependentMedDRA: Rhinorrhoea, Sneezing — Feeling: Fair · Be unable to work or attend schoolFree text: Sneezing and runny noseMedDRA releases: 2024-11 · check-in free text available
- 2022-05-28
- 2022-06-04
- 2022-06-13
- 2022-06-18
- 2022-06-27
- 2022-07-02
- 2022-08-20
- 2022-11-19
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2022-04-30 | Pfizer-BioNTech | No |
| 2 | 2022-05-21 | Pfizer-BioNTech | No |
Free text
Release 11 — days 1–6 daily, dose 2, dependent
Systemic reaction (other): Sneezing and runny nose
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SRO | Rhinorrhoea | · | · | ✓ |
| SRO | Sneezing | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release